Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22993
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Camptothecin/adverse effects/*analogs & derivatives/therapeutic use,Carcinoma, Small Cell/*drug therapy/pathology,Cisplatin/adverse effects/*therapeutic use,Disease Progression,Dose-Response Relationship, Drug,Drug Therapy, Combination,Etoposide/adverse effects/*therapeutic use,Female,Humans,Lung Neoplasms/*drug therapy/pathology,Male,Middle Aged,Survival Rate
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/22993
ISSN: 0169-5002
Link: http://www.ncbi.nlm.nih.gov/pubmed/17698241
http://ac.els-cdn.com/S016950020700400X/1-s2.0-S016950020700400X-main.pdf?_tid=6fda7be28bdd84412d029e4e6eb44bf7&acdnat=1333703544_dd61f8cad53cb795221b0d9e25bb4862
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Pectasides-2007-Combination chemothe.pdf180.03 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons